Bryan Giraudo
Directeur Financier/CFO chez GOSSAMER BIO, INC.
Fortune : 760 620 $ au 30/04/2024
Profil
Mr. Bryan Giraudo is an Independent Director at Valerio Therapeutics SA, an Independent Director at Protagonist Therapeutics, Inc. and a Chief Operating & Financial Officer at Gossamer Bio, Inc. He is on the Board of Directors at Valerio Therapeutics SA and Protagonist Therapeutics, Inc. Mr. Giraudo was previously employed as a Senior Managing Director by SVB Securities LLC, a Managing Director by Merrill Lynch & Co., Inc., and a Managing Director by Pierce Fenner & Smith, Inc. He received his undergraduate degree from Georgetown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 18 000 ( 0,03% ) | 443 880 $ | 30/04/2024 | |
GOSSAMER BIO, INC.
0,21% | 16/04/2024 | 472 747 ( 0,21% ) | 316 740 $ | 30/04/2024 |
Postes actifs de Bryan Giraudo
| Sociétés | Poste | Début |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/05/2018 |
| GOSSAMER BIO, INC. | Directeur Financier/CFO | 07/05/2018 |
| VALERIO THERAPEUTICS | Directeur/Membre du Conseil | 23/11/2021 |
Anciens postes connus de Bryan Giraudo
| Sociétés | Poste | Fin |
|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Corporate Officer/Principal | 01/05/2018 |
| Merrill Lynch & Co., Inc. | Corporate Officer/Principal | 01/07/2009 |
| Pierce Fenner & Smith, Inc. | Corporate Officer/Principal | - |
Formation de Bryan Giraudo
| Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| VALERIO THERAPEUTICS | Health Technology |
| Entreprise privées | 3 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
| Merrill Lynch & Co., Inc. | Finance |
| Pierce Fenner & Smith, Inc. | Finance |